- 6951
- 383
- 10
- 6
- 0
- Help Ukraine
About the solution
This is something to which few Type 1 diabetics in Britain have access – the monitors cost around £4,000 a year to buy and maintain and are too expensive for the NHS.
“I now have more information about my condition, so I better understand what I am doing. I feel more in control – and that is a massive improvement,” he says.
Tim decided to create his own glucose monitor because he was tired of waiting for the pharmaceutical and medical device companies to come up with new, affordable ways to improve the lives of diabetic patients, he has taken matters into his own hands. So he bought an old continuous glucose monitor (CGM) from the internet and used his skills as an IT specialist to re-engineer it so that it communicates, via a self-built Tic Tac box receiver he keeps in his pocket, with his mobile phone and his smartwatch – something even the full-price version will not do. The total annual cost is about £1,000. With a couple of taps on the screen, his blood glucose level is displayed as a graph.
“Diabetes is all about managing your data – on medication, food and blood glucose,” says Omer. “Current tools are not up to the job and I struggle to keep up. We need help.” His next goal is to obtain an automatic calculation of the amount of insulin he needs, based on his glucose level and other factors, as a step towards creating an artificial pancreas. He has teamed up with the charity Great Britain Diabetes Online Community to bring his findings to a wider audience.
“My aim is to publish my work, and others’, so as many people as possible can benefit. If you try to commercialise [your own products], you run up against all sorts of regulatory barriers,” he says.
Adapted from: http://bit.ly/1P1K9Lb
More info: http://www.hypodiabetic.co.uk/
This solution shall not include mention to the use of drugs, chemicals or biologicals (including food); invasive devices; offensive, commercial or inherently dangerous content. This solution was not medically validated. Proceed with caution! If you have any doubts, please consult with a health professional.
DISCLAIMER: This story was written by someone who is not the author of the solution, therefore please be advised that, although it was written with the utmost respect for the innovation and the innovator, there can be some incorrect statements. If you find any errors please contact the patient Innovation team via info@patient-innovation.com
-
-
426
-
0
-
11893
Nightscout – an open source, do-it-yourself continuous glucose monitor in the Cloud
Type 1 diabetes mellitus
Diabetes insipidus
Diabetes mellitus
Diabetes mellitus (incl subtypes)
Diabetes mellitus inadequate control
Fulminant type 1 diabetes mellitus
Cystic fibrosis related diabetes
Gestational diabetes
Insulin-requiring type 2 diabetes mellitus
Latent autoimmune diabetes in adults
Diabetes with hyperosmolarity
Diabetes complicating pregnancy
Insulin resistant diabetes
Type 2 diabetes mellitus
Type 3 diabetes mellitus
Pancreatogenous diabetes
Glucose metabolism disorders (incl diabetes mellitus)
Nephrogenic diabetes insipidus
Acquired lipoatrophic diabetes
Congenital central diabetes insipidus
Hyperglycaemia
Carbohydrate metabolism disorder
Inborn errors of carbohydrate metabolism (excl glucose)
Pancreas
Mobile app
Software
Insulin injector
Insulin pen
Insulin injection
Diabetes mellitus management
-
-
-
405
-
0
-
9927
I-Port™ – Medication delivery device
Type 1 diabetes mellitus
Diabetes complicating pregnancy
Diabetes mellitus
Diabetes mellitus (incl subtypes)
Diabetes mellitus inadequate control
Latent autoimmune diabetes in adults
Insulin resistant diabetes
Insulin-requiring type 2 diabetes mellitus
Pancreatogenous diabetes
Type 2 diabetes mellitus
Type 3 diabetes mellitus
Gestational diabetes
Glucose metabolism disorders (incl diabetes mellitus)
Crohn's disease
Rheumatoid arthritis
Hypopituitarism
Dwarfism
Autoimmune disorders
Coagulopathy
Pancreas
Pituitary gland
Auto-injector
Insulin injector
Insulin pen
Insulin injection
Skin and subcutaneous tissue therapeutic procedures
Anticoagulant therapy
-
-
-
349
-
11
-
9562
Diabetic invents app to manage diabetes
Diabetes mellitus (incl subtypes)
Diabetes mellitus inadequate control
Acquired lipoatrophic diabetes
Diabetes mellitus
Diabetes with hyperosmolarity
Congenital central diabetes insipidus
Diabetes complicating pregnancy
Diabetes mellitus malnutrition-related
Diabetes insipidus
Cystic fibrosis related diabetes
Insulin-requiring type 2 diabetes mellitus
Type 1 diabetes mellitus
Congenital nephrogenic diabetes insipidus
Insulin resistant diabetes
Fulminant type 1 diabetes mellitus
Gestational diabetes
Latent autoimmune diabetes in adults
Type 2 diabetes mellitus
Type 3 diabetes mellitus
Pancreatogenous diabetes
Nephrogenic diabetes insipidus
Mobile app
-